This post is espec for you, Predictor.
Time to load the boat and but more THLD. With Ziopharm's collapse, THLD is gonna explode up, maybe even soon...
CLSN, PPHM, AFFY and now ZIOP are good examples of the risk we are taking investing in these bio specs.
Not for the faint of heart.
Yes, you're right, Syenfrout!
Another moral of story: don't hold through pivotal event, looking for the killing. You can often do very well with the run-ups and getting out before trial results.
I am pretty leveraged but I will try to pick up a few more shares. Thanks.